Navigation Links
Cellular System Causing Destruction Of Faulty Proteins In Cystic Fibrosis Identified

Researchers from University of North Carolina at Chapel Hill have managed to isolate a cellular system responsible for degrading proteins in Cystic Fibrosis. Blocking this// system allows some affected proteins to regain their shape and thus may herald in new treatments for the disease.

Cystic fibrosis (CF) is a fatal disease caused by a defective gene that produces a misshapen form of the protein cystic fibrosis transmembrane conductance regulator (CFTR). People with cystic fibrosis do not have enough CFTR for their cells to work normally because their bodies quickly destroy the mutant protein.

"Most cases of CF are caused by the inability of faulty CFTR to get in the correct shape, which leads cells to place it in the trash bin," said senior author Dr. Douglas Cyr, professor of cell and developmental biology at UNC School of Medicine. "Our research helps define the basic mechanism for CF and identify targets for the development of therapeutics designed to get CFTR into shape and allow it function normally in the lung," Cyr said.

The results, published Aug. 11, 2006, in the journal Cell, point to several possible targets for the development of new treatments aimed at stopping the disease, the researchers said.

Scientists have known for some time that treatment of cultured cells with compounds known as chemical chaperones can increase the fitness of misshaped CFTR and get it into proper shape. Thus, "If we can figure out how to get CFTR into the right shape, we can cure the disease," Cyr said.

To better understand how to fix CFTR, Cyr's research team at the UNC Cystic Fibrosis Pulmonary Research and Treatment Center focused on identifying the cellular system that disposes of faulty CFTR. The investigators identified cell components that specifically recognizes misshapen CFTR and drops it in the molecular trash bin. The team found that turning off these components – the cell's trash collectors -- exten
'"/>




Page: 1 2

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Researchers Discover Two Proteins Involved In Cellular Destruction Of HIV Virus
3. Unchecked Cellular Repair Pathway Causes Liver Cancer
4. New Way to Open Cellular Ion Channels, Implications for Drug Design
5. Gene May Regulate Cellular Aging
6. Cellular Cues Identified for Stroke Recovery
7. Cellular Pathway Yields Potential New Weapon in Vaccine Arsenal
8. Cocaines Use During Pregnancy May Cause Lasting Cellular Effects
9. Early Warning System For Breast Cancer
10. Gene connected to Multi-System disorder discovered
11. Reviving the Immune System
Post Your Comments:
(Date:10/10/2008)...LE, PA The American Nurses Credentialing Center (...) as a Magnet hospital. The news came via a confer...taff who broke out with cheers and applause., GMC...itals and only 294 hospitals in the United States... hospitals are eligible for this recognition., "A...
(Date:10/10/2008)...ggests poor self-care partly to blame , ,...f Medicare beneficiaries who have diabetes, being ... according to a new study. , Publishing in th...l Medicine , researchers from the University of Wa...erage age of 75.6 years) who had diabetes and were...
(Date:10/10/2008)... Honoring excellence in the imple... Healthcare Information and Management Systems Soc...Davies Awards in the Organizational, Ambulatory an... Chicago, IL (PRWEB) October 1...on of electronic health records (EHRs), the Healt...
(Date:10/10/2008)...YORK, Oct. 10 /PRNewswire/ -- The Johns Hopkins Un...ultimedia educational program,"Optimizing Adjuvan...atment,Selection," to present recent key research ...ment., In recent years, advancements in the treat... and biologic treatment combinations that are,incr...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2
... follows weight pattern in France reveals that Fre...and fatter//. According to the ObEpi-Roche survey...5 years is affected by weight problem, with 1/3rd ... obese.Obesity is on a high in France, in spite of...
...the next school year will probably see a promotion...le to apply for a chunk// of a $3-million-a-year N... $12 million Nutrition Fund as part of its support... Government. Schools and early childhood centers...
...earchers suggest a short-term application of topic...ent agent for patients// with intertriginous psori...eptember issue of Archives of Dermatology, one of ... is an inflammatory skin disease. In a subset of ...
...researchers at Manchester University, hearing voic...ses the traditional belief//. A Dutch report revea...n fact, several people who hear voices do not seek... voice has a positive effect on them by calming or...
Other Medicine News:Health News:Obesity on a high in France 2Health News:Better Nutrition in Schools Boosted by $12m Fund 2Health News:Short-Term Topical Corticosteroid May Offer Relief for Certain Type of Psoriasis 2Health News:Hearing voices may be normal 2
(Date:10/9/2008)...al Results Expected in November 2008, BOTHELL, Wa..., Inc.,(Amex: DDD ) announced today the completio...f its three pivotal trials to evaluate the safety ...d-release (ER) ibuprofen for,the over-the-counter ...ne,results from this pivotal trial in November 200...
(Date:10/8/2008)...Someday Inform Treatments for Spinal Cord, Other N...-USNewswire/ -- A protein that enables,nerve cells...n controlling,the developing nervous system. Resea...s to form among nerve cells may provide a basis fo...ries to their nervous system,including spinal cor...
(Date:10/8/2008)...Confirm Potency of Poly-ICR as Vaccine Adjuvant, ... Biopharmaceuticals,Corporation (TSX: NVN) today p...ing its proprietary Toll-like Receptor 3 agonist, ...cine Congress 2008 in Lyon, France.,Study results ...ant,targeting the Toll-like Receptor 3 (TLR3) path...
(Date:10/7/2008)... efficacy of new device for detecting polyps that ...copy, ORLANDO, Fla., Oct. 7 /- At th...ntific Meeting in Orlando (ACG 2008), renowned,gas...ts from a,multi-institutional clinical study that ...ope(R), a new device that is designed to improve t...
Breaking Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 2National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 3National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 4National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon 5Preeclampsia Linked to Heart Disease Risk 5393 1Preeclampsia Linked to Heart Disease Risk 5393 2Preeclampsia Linked to Heart Disease Risk 5393 3Cornell will host the Northeast Biofuel Summit Nov 11 13 1087 1Mannatech Hosts Australasian Convention 5389 1Mannatech Hosts Australasian Convention 5389 2Mannatech Hosts Australasian Convention 5389 3American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 1American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 2American Medical Womens Association Supports New Bill That Requires Medicare Coverage of HPV Testing as Part of Cervical Cancer Screening 5386 3
... 8, 2007 - Late-breaking Phase III,clinical trial ...ety on Thrombosis and Haemostasis (ISTH) Congress ...uperior efficacy in the,prevention of venous throm...cement surgery in a head-to-head comparison with,e...in the RECORD3,(REgulation of Coagulation in major...
...ess with Positive Phase IIa Clinical,Trial Results...lication of Key,Product in AM-Pharma,s Pipeline , ...V., the,biopharmaceutical company developing novel... diseases, today announced the positive,clinical r...trial,for patients with ulcerative colitis, a chro...
Other Medicine Technology:Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: